PNC Financial Services Group’s Palvella Therapeutics PVLA Stock Holding History

PNC Financial Services Group’s Portfolio PVLA Stock Details PVLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.74K	Buy	31 +1	+3%	+$121	﹤0.01%	4411
2026 Q1	$3.74K	Hold	30	–	–	﹤0.01%	4391
2025 Q4	$3.14K	Buy	30 +20	+200%	+$1.71K	﹤0.01%	4405
2025 Q3	$627	Buy	+10	New	+$446	﹤0.01%	4761
2020 Q1	–	Sell	-13	Closed	-$4K	–	4073
2019 Q4	$4K	Hold	13	–	–	﹤0.01%	3708
2019 Q3	$3K	Hold	13	–	–	﹤0.01%	3830
2019 Q2	$5K	Hold	13	–	–	﹤0.01%	3752
2019 Q1	$3K	Hold	13	–	–	﹤0.01%	3840
2018 Q4	$3K	Hold	13	–	–	﹤0.01%	3816
2018 Q3	$6K	Hold	13	–	–	﹤0.01%	3800
2018 Q2	$5K	Hold	13	–	–	﹤0.01%	3850
2018 Q1	$7K	Buy	+13	New	+$8.05K	﹤0.01%	3834

Other funds holding PVLA

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

CAM

Clio Asset Management Charlottesville, Virginia $126M AUM 16.01% 1-Year Est. Return

Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

LCM

Legato Capital Management San Francisco, California $1.21B AUM 82.36% 1-Year Est. Return

PNC Financial Services Group's PVLA Position: Q2 2026 in Review

PNC Financial Services Group increased its Palvella Therapeutics (PVLA) stake by 3.3% in Q2 2026, buying an estimated $121 and bringing the position to 31 shares worth $4.74K. The position accounts for ﹤0.01% of the portfolio, ranked #4411.

PNC Financial Services Group first reported a position in PVLA in Q1 2018 and has held it in 12 quarters since. The position peaked at $7K in Q1 2018. 63 funds tracked by Wall St. Rank hold PVLA as of Q2 2026.

PNC Financial Services Group held 31 shares of Palvella Therapeutics worth $4.74K as of Q2 2026.
PNC Financial Services Group bought 1 Palvella Therapeutics share in Q2 2026, an estimated $121.
Palvella Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4411 holding.
PNC Financial Services Group first reported a position in Palvella Therapeutics in Q1 2018 and has held it in 12 quarters since.
PNC Financial Services Group's Palvella Therapeutics position peaked at $7K in Q1 2018.
63 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.